← Back to Search

Remote monitoring for Infantile Spasms

N/A
Recruiting
Led By Jennifer D Coffman, BSN
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at therapy completion (end of week 4, with 7 days to complete)
Awards & highlights

Study Summary

This trial is studying whether a new telemedicine technology can help with parental stress, costs, and overall satisfaction in care for families who have children with a specific seizure type called infantile spasms.

Eligible Conditions
  • Infantile Spasms, Non-Intractable

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at therapy completion (end of week 4, with 7 days to complete)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at therapy completion (end of week 4, with 7 days to complete) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Compare expenses between intervention group and control group
Compare overall satisfaction with treatment between intervention group and control group
Compare parental stress between intervention group and control group

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
This group will be provided remote monitoring technology where they will be able to monitor blood pressure at home. In addition, they will receive a nurse-led telemedicine visit at one week and three weeks of therapy. Like the control group, they will still receive a two-week EEG and Neurology appointment.
Group II: Control GroupActive Control1 Intervention
This group will continue to receive standard care for ACTH monitoring and follow-up with includes blood pressure by the patient's PCP while on therapy, a one week nursing follow-up phone call, and a two-week EEG and Neurology appointment.

Find a Location

Who is running the clinical trial?

MallinckrodtIndustry Sponsor
201 Previous Clinical Trials
16,188 Total Patients Enrolled
University of Colorado, DenverLead Sponsor
1,734 Previous Clinical Trials
2,148,843 Total Patients Enrolled
Jennifer D Coffman, BSNPrincipal InvestigatorChildren's Hospital Colorado

Media Library

Remote monitoring Clinical Trial Eligibility Overview. Trial Name: NCT04086992 — N/A
Infantile Spasms Research Study Groups: Intervention Group, Control Group
Infantile Spasms Clinical Trial 2023: Remote monitoring Highlights & Side Effects. Trial Name: NCT04086992 — N/A
Remote monitoring 2023 Treatment Timeline for Medical Study. Trial Name: NCT04086992 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are applications being accepted for this experimental protocol?

"This clinical trial is still in need of participants, as indicated on the official listing hosted by clinicaltrials.gov. The initial post date for this study was October 10th 2019, and it has been actively updated until May 2nd 2022."

Answered by AI

What is the highest capacity for participants in this research endeavor?

"Affirmative. The information posted on clinicaltrials.gov indicates that this medical trial is currently enrolling volunteers; the original post was dated October 10th 2019 and it was last modified May 2nd 2022. This study necessitates 40 individuals from one specific location."

Answered by AI

Is the age of eligibility for this clinical trial greater than twenty years?

"Patients between one month and two-and-a-half years old are eligible to enroll in this medical research."

Answered by AI

Who meets the criteria for this medical experiment?

"In this research endeavour, the requisite enrollees must be under 30 months old, admitted at CHCO, Anschutz or Colorado Springs hospitals for initial ACTH treatments and suffering from limb cramps. Furthermore, their primary caretaker (parent/guardian) is necessary to complete enrollment. The trial has a cap of 40 participants in total."

Answered by AI
Recent research and studies
~7 spots leftby Apr 2025